United Advisor Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$264K	Buy	+594	New	+$264K	0.05%	333
2024 Q4	–	Sell	-434	Closed	-$202K	–	401
2024 Q3	$202K	Buy	+434	New	+$202K	0.05%	336